For information on our biotechnology and pharmaceutical capability, please contact Stephen Taylor.
Novartis Vaccines
Upgrades to vaccines suites
Liverpool, UK
As part of CEL’s five year relationship with Novartis Vaccines, they have been responsible for several upgrade projects within existing areas. These are all highly confidential.
Return to our biotechnology project experience.
Return to our biotechnology capability.
Return to our pharmaceutical project experience.
Return to our pharmaceutical capability.
![[CEL logo]](../graphics/logo.gif)